Trends in Buprenorphine Coverage and Prior Authorization Requirements in US Commercial Formularies, 2017-2021.

Nguyen, Thuy D; Chua, Kao-Ping; Andraka-Christou, Barbara; Bradford, W David; Simon, Kosali

Nguyen, Thuy D; Chua, Kao-Ping; Andraka-Christou, Barbara; Bradford, W David; Simon, Kosali.

Afiliación

Nguyen TD; Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor.
Chua KP; Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor.
Andraka-Christou B; Susan B. Meister Child Health Evaluation and Research Center, Department of Pediatrics, University of Michigan Medical School, Ann Arbor.
Bradford WD; School of Global Health Management and Informatics, University of Central Florida, Orlando.
Simon K; Department of Public Administration and Policy, University of Georgia, Athens.

JAMA Health Forum ; 3(7): e221821, 2022 07.

Article en En | MEDLINE | ID: mdl-35977219

Asunto(s)

Buprenorfina; Autorización Previa; Buprenorfina/uso terapéutico; Estudios Transversales

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Buprenorfina / Autorización Previa Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: JAMA Health Forum Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google